Delivery Order SPE2DB25D9320-SPE2DB25FWFBY
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 2, 2025, for the supply of Jakafi 5 mg tablets (60 count) with a contract value of $24,293.60. This firm fixed-price delivery order, with an ultimate completion date of September 3, 2025, represents a fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through November 2026. The award was made without a set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. on August 4, 2025, for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. This award utilizes a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete directly in the...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a direct pharmaceutical supply transaction under DMS's existing Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the awardee under a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 11, 2025, with performance to be executed at the vendor's Park Ridge location. No...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $36,440.37 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of July 9, 2025. This delivery order was awarded without a set-aside designation on July 8, 2025. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 2, 2025, for Jakafi 10 mg tablets (60-count units) valued at $12,915.65. This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, with an ultimate completion date of September 3, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-unit quantity) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation applied. This award falls under DMS Pharmaceutical Group's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain, through its SPE2DB Indefinite Delivery Contract vehicle, awarded a delivery order to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 20 mg, with a ceiling value of $36,269.34. This firm fixed-price delivery order, issued on July 24, 2025, represents a single line item fulfillment under DMS Pharmaceutical Group's existing $499.999 billion master contract with DLA, which remains valid through November 2026. The delivery is scheduled...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 5 mg on June 17, 2025. This firm fixed-price delivery order, with an ultimate completion date of June 18, 2025, is being fulfilled from Park Ridge, Illinois. The award utilizes no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical procurement...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB25FWFBYDelivery Order
On July 31, 2025, the Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 10 mg tablets (60-count packages). This firm fixed-price delivery order, designated as contract 4568977633, represents a continuation of pharmaceutical supply services under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract carries no set-aside designation, and the ultimate completion date is August 1, 2025. Performance will be conducted at the vendor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime contractor on this award with no identified subcontractors. The company has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to Defense Department healthcare facilities nationwide. This delivery order for Jakafi—a pharmaceutical treatment for certain blood disorders—continues DMS Pharmaceutical Group's role as a critical supplier supporting the medical readiness of military health systems across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 7/31/25 |